May 14, 2020 / 10:14 AM / in 15 days

BRIEF-Fennec Pharmaceuticals Announces Q1 2020 Financial Results

May 14 (Reuters) - Fennec Pharmaceuticals Inc:

* FENNEC PHARMACEUTICALS ANNOUNCES FIRST QUARTER 2020 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

* Q1 LOSS PER SHARE $0.19

* Q1 EARNINGS PER SHARE ESTIMATE $-0.19 — REFINITIV IBES DATA

* FDA SET A PDUFA TARGET ACTION DATE FOR PEDMARK(TM) OF AUGUST 10, 2020

* COMMERCIAL READINESS ACTIVITIES ARE UNDERWAY IN U.S. Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below